Chlvpp Therapy for Hodgkin's Disease Identification of Prognostic Factors
Author:
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 15 (sup1) , 13-14
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.Journal of Clinical Oncology, 1991
- ChlVPP combination chemotherapy for Hodgkin's disease: long term resultsBritish Journal of Cancer, 1990
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.Journal of Clinical Oncology, 1985
- A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's diseaseBritish Journal of Cancer, 1977